share_log

8-K: SUNSHINE BIOPHARMA REPORTS 2024 FIRST QUARTER RESULTS: REVENUES UP 54%

SEC ·  May 22, 2024 20:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 944

Recommended